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Structured Summary 
Objectives: To describe the prevalence of pancreatic, hepatic and renal microscopic lesions in post-
mortem samples from Cavalier King Charles Spaniels (CKCS) presented to a UK post-mortem 
collection scheme. 
Methods: Histopathology was performed on the organs of interest and the prevalence of microscopic 
lesions described, this was related back to the clinical signs shown ante-mortem. 
Results: Evidence of chronic pancreatitis was seen in 51.9% of the cases, and age correlated with 
severity of disease, suggesting that chronic pancreatitis is a progressive condition. Evidence of renal 
lesions was present in 52.2% of cases, most commonly inflammatory disease. The rate of ante-
mortem diagnosis was low for both pancreatic and renal disease, at 25% and 16.7% respectively. 
Primary hepatic lesions were present in only 11.1% of cases, but secondary hepatic lesions were 
more common and were present in 64.8%. 
Clinical Significance: Pancreatic and renal lesions are common in Cavalier King Charles Spaniels 
and clinicians should be aware of this when presented with clinical cases, they have similar rates of 
hepatic disease as the general population. 
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Introduction 
The Cavalier King Charles Spaniel (CKCS) is a common breed in the United Kingdom. The breed is 
commonly reported to suffer from chronic mitral valve disease (Beardow and Buchanan 1993) and 
syringomyelia (Rusbridge et al. 2000), however less information exists on other conditions, such as 
pancreatic, renal and hepatic disease, although there is a suspicion of an increased prevalence of 
chronic pancreatitis in the breed (Watson et al. 2007).  
 
The Cavalier collection scheme* was initially started by motivated cavalier owners and breeders, in 
order to obtain post-mortem samples of the central nervous system (CNS) from CKCS which had 
had MRI prior to death to gain a better understanding of syringomyelia. It was then extended to 
include samples of mitral valve for further studies of chronic valvular disease. More recently, as 
increasing recognition of other diseases developed, the scheme was extended again to include 
pancreatic, hepatic and renal samples. 
 
Pancreatic, renal and hepatic diseases can be difficult to diagnose ante-mortem, due to the non-
specific nature of clinical signs, a lack of highly sensitive diagnostic tests and variable disease 
progression. They can, however, cause significant morbidity in affected dogs and so an indication of 
prevalence would be useful to help guide clinicians to undertake appropriate diagnostic tests in living 
animals. 
 
This study aimed to assess the prevalence of pancreatic, renal and hepatic lesions in a population of 
CKCS presented to a post-mortem collection scheme and to relate these back to the clinical history 
of those dogs. In addition, the study also aimed to assess whether there was any statistically 
significant association between the 
different abnormalities detected. 
*http://www.thecavaliercollectionscheme.org 
 Materials and methods 
Sections of pancreas, liver and kidney were taken from the dogs presented to the Cavalier collection 
scheme by their owners with fully informed consent. In a small number of dogs samples were only 
available for one or two of these organs. Some of these cases underwent a full post-mortem 
examination at one of the participating centres, whilst some cases had samples of the appropriate 
organs collected by veterinary surgeons in first-opinion practice in the UK. Full instructions were 
sent to the veterinary surgeons to ensure consistent sample collection (supplementary file 1). CNS 
samples were only taken if the dog had a post-mortem examination at an appropriate centre. 
 
Each dog’s case also required completion of the submission form for the collection scheme, 
containing questions about relevant medical history. Some cases also had a full clinical history 
available.  Medical history required included age and presence or absence of neurological, 
cardiovascular or gastrointestinal signs and any concurrent diseases (supplementary file 2 and 3). 
 
All tissue samples were fixed in 10% neutral buffered formalin solution before being embedded in 
paraffin. The paraffin sections (5μm) were then stained with hematoxylin and eosin (H & E) and 
reviewed by two of the authors. 
 
Pancreatic lesions were categorised as previously published (Newman et al. 2006, Watson et al. 
2007). Chronic pancreatitis was defined as a lymphocytic or mixed inflammatory infiltrate (clusters 
of lymphocytes, plasma cells, macrophages, neutrophils in combination with tissue changes) with or 
without fibrosis, with disruption of the normal pancreatic architecture. All of the pancreas sections 
were allocated to one of the following categories based on Newman et al 2006: 
a) No evidence of chronic pancreatitis. Scored as 0. 
b) Mild chronic pancreatitis: one or two small foci of lymphocytic infiltrate and mild fibrosis in 
the section examined occupying less than 10% of the area. Scored as 1. 
c) Moderate chronic pancreatitis: multi-focal areas of fibrosis and lymphocytes in the section 
examined but involving less than 40 per cent of area. Scored as 2. 
d) Marked chronic pancreatitis: multi-focal areas of marked fibrosis and lymphocytic 
inflammation producing gross distortion of the normal architecture and affecting >40% of 
tissue. Scored as 3. 
e) “End-stage” was regarded as virtually no normal acinar tissue remaining. Scored as 4. 
 
The liver lesions were assessed according to the WSAVA standards for liver histopathology 
(Rothuizen 2006) and allocated to one of the following categories: 
a) No evidence of hepatic disease. 
b) Primary hepatic disease. 
I. Chronic hepatitis: hepatocellular apoptosis or necrosis with an inflammatory infiltrate 
(mononuclear or mixed) and varying degrees of fibrosis. 
II. Acute hepatitis: a combination of acute inflammation, hepatocellular apoptosis and 
necrosis, which may be accompanied by regeneration. 
III. Neoplasia. 
c) Secondary hepatic disease 
I. Hepatic congestion: engorgement and dilation of the hepatic veins and centrilobular 
sinusoids, which may be accompanied by dilated lymphatics and centrilobular 
perivenular fibrosis. 
II. Hepatic vacuolation: hydropic change or fatty change. 
III. Reactive hepatitis: inflammatory infiltrate in the portal areas or parenchyma with no 
hepatocellular necrosis. 
 Renal lesions were assessed into the following categories (Macdougall et al. 1986): 
a) Normal 
b) Inflammatory disease 
I. Glomerulonephritis: proliferation of the endothelial and epithelial cells of the 
glomerular capillary with thickening of the glomerular basement membrane. 
II. Interstitial Nephritis: a mixed inflammatory infiltrate of the interstitium 
c) Other abnormalities. 
 
Dogs were excluded if neither a complete clinical history nor a complete submission form was 
available. Some cases did not have samples available from each organ. 
 
Dogs were considered to have had clinical signs that may have been consistent with chronic 
pancreatitis if they had frequently reported episodes of gastrointestinal signs (vomiting, diarrhoea, 
inappetence) or abdominal pain (Watson 2012). A clinical diagnosis of renal disease was based on 
the identification of azotaemia, in the face of poorly concentrated urine (Lees 2004). 
 
Prevalence of microscopic lesions were calculated for each organ and compared to the prevalence of 
clinical signs.. Relative risk was calculated for having renal disease together with chronic 
pancreatitis. It was considered significantly increased only if the risk and 95% confidence interval 
were greater than 1. Dogs with and without pancreatic lesions were compared for any significant 
differences in signalment. To document any increase in severity of chronic pancreatitis with age, 
Kendall’s Tau rank correlation coefficient was used to compare age with chronic pancreatitis score. 
 
Results 
Fifty-nine dogs were initially included in the study, five were subsequently excluded due to 
unavailable histopathology (two) or unavailable clinical history (three), leaving 54 dogs for analysis. 
 
The dogs’ age ranged from 3 to 16 years (mean 10.4 years, median 10.9 years) and from 6 to 15.7kg 
in weight (mean 9.3kg, median 9.3kg). Dogs were euthanased or died for a number of reasons, 
including congestive heart failure (15), syringomyelia (10), other neurological disorders (11, most 
commonly degenerative myelopathy or seizures), neoplasia (6), renal disease (3), old age (3), liver 
disease (2), pancreatic disease (2), and 1 each of severe anaemia and aggression. 
 
Eighteen dogs underwent a full post-mortem examination, the remainder had the relevant organs 
sampled by veterinary surgeons in practice. Twelve dogs also had histopathology performed on the 
CNS, these have been reported as part of a previous study (Hu et al. 2012). 
 
Twenty-four dogs (44.4%) were being treated for cardiac disease at the time of death with a number 
of medications including one or more of the following list: frusemide, pimobendan, spironolactone, 
benazepril, torsemide and digoxin.  Twenty-five dogs had an ante-mortem diagnosis of 
syringomyelia, some of which were receiving medical therapy including one or more of the 
following drugs: frusemide, gabapentin, prednisolone, and non-steroidal anti-inflammatory drugs. 
 
The prevalence of microscopic lesions, and association with clinical signs, is described in tables 1-3. 
Examples of some of the most common abnormalities are demonstrated in figures 1-5 (pancreatic 
disease), and figure 6 (renal disease). 
 
There was a weak but significant positive correlation between age and severity of chronic 
pancreatitis (taub correlation coefficient = 0.3; p = 0.003). 
 When considering inflammatory diseases, 8 dogs had both chronic pancreatitis and renal disease, 3 
dogs had chronic pancreatitis and inflammatory liver disease and 1 dog had chronic pancreatitis, 
renal disease and inflammatory liver disease.  
 
There was no increase in the relative risk of glomerulonephritis or interstitial nephritis in dogs with 
chronic pancreatitis (relative risk 0.8250, 95% CI 0.414 to 1.645, P=0.58). There was also no 
increased risk of vacuolar hepatopathy in dogs with chronic pancreatitis (relative risk 0.6845, 95% 
CI 0.364 to 1.289, P=0.24). There was no increased relative risk of hepatic congestion in dogs with 
cardiac disease (relative risk 0.9900, 95% CI 0.508 to 1.928, P=0.976). Whilst the relative risk of 
inflammatory kidney disease was increased in dogs with cardiac disease (relative risk 1.3228, 95% 
CI 0.664 to 2.634, P=0.43), the confidence interval falls below 1 so it is unclear how significant the 
association is. 
 
Discussion 
This is the first study to examine the prevalence of histopathologically confirmed pancreatitis, renal 
and liver disease in a large population of CKCS examined at post-mortem. Whilst the prevalence of 
pancreatitis in the dog has been examined in previous studies (Newman et al. 2004, Watson et al. 
2007), this is the first study to focus on only one breed. This study shows the prevalence of chronic 
pancreatitis in the CKCS is 51.9%, which is greater than the 34% reported in a large study looking at 
post-mortem samples from a variety of breeds (Watson et al. 2007). That study included 6 CKCS, all 
of which had evidence of chronic pancreatitis. The prevalence of renal disease was also very high in 
this study at 52.2% and yet the proportion of dogs with ante-mortem diagnosis of either chronic 
pancreatitis or renal disease was very small. The prevalence of hepatic lesions is very similar to that 
reported in the general population (Watson at al. 2010b). 
 Chronic pancreatitis is suspected to be an under-diagnosed disease, mainly due to the vague nature of 
the clinical signs (Watson 2004) and this study supports that. We found that only 24% of the cases 
with histological evidence of chronic pancreatitis had been diagnosed ante-mortem. This may be 
because the clinical signs were very intermittent, interpreted to represent an alternative disease or 
because the clinical signs were genuinely so subtle. However, chronic pancreatitis is known to be an 
important cause of chronic pain in dogs (Watson et al. 2010a, Bostrom et al. 2013) and in humans 
(Bouwense et al. 2013). The pain in humans results in a significant upregulation of central 
nociception, which is more marked the more severe the disease is (Bouwense et al. 2013). It is 
possible that cavaliers with chronic pancreatitis suffer from chronic pain, which may be over-looked 
or confused in some cases with the neuropathic pain of syringomyelia.  It is therefore important for 
veterinary practitioners to be aware of chronic pancreatitis in cavaliers and to institute appropriate 
management including analgesics with the aim of reducing the morbidity. 
 
Gastrointestinal clinical signs are commonly reported in Cavalier King Charles Spaniels, affecting 
19.3% of dogs in a recent study (Summers et al. 2015), and it is possible that this is due to chronic 
pancreatitis in a significant number of cases, considering the high prevalence in this study. However, 
34.6% of the dogs without histopathological evidence of chronic pancreatitis also had clinical signs 
which could have been consistent with this disease, suggesting that other gastrointestinal diseases are 
also common in this breed. 
 
A weak, but significant correlation was identified between age and severity of chronic pancreatitis, 
this suggests that chronic pancreatitis is a progressive disease which worsens with age in this breed. 
 
This is the first study to report the prevalence of renal disease in Cavalier King Charles Spaniels. 
Glomerulonephritis or interstitial nephritis was identified in 19 dogs (41%) in this study, whilst only 
4 dogs had an ante-mortem diagnosis of renal disease. 24 dogs (44.4%) in this study had congestive 
heart failure and were on long-term medication for cardiac disease and this may mean that subtle 
changes in renal function were overlooked. Many of the dogs were on medications that may have 
had an impact on renal perfusion, for example angiotensin converting enzyme inhibitors (ACEi) and 
diuretics and the assumption may have been that mild azotaemia was due to reduced renal perfusion 
or the effects of diuresis. However, the changes identified on histopathology were indicative of 
primary renal disease in many dogs. It is likely that at least some dogs with glomerulonephritis had 
measurable proteinuria and some dogs with nephritis had poorly concentrated urine. However, the 
retrospective nature of these samples means that we do not have comprehensive information on 
indicators of renal function in most dogs, and the standard ante-mortem tests for assessing renal 
function are relatively insensitive. It is very important to increase recognition of chronic renal 
disease in CKCS ante-mortem because there is strong evidence that changing dogs on to a phosphate 
restricted diet formulated for renal disease can increase life-expectancy by a factor of 3 (Jacob et al. 
2002). However, clinicians also need to be aware that renal diets generally have elevated fat 
concentrations, which may be problematic if the dog also has chronic pancreatitis. Renal or urinary 
disorders only affected 4.5% of Cavalier King Charles Spaniels presenting to primary-care practices 
(Summers et al. 2015) suggesting that clinicians may need to be more proactive in screening for 
these diseases. The very different populations between these two studies likely accounts for some of 
this difference. 
 
Hepatic lesions were commonly detected in this study but the majority of cases had secondary 
findings likely to be related to other diseases. The finding of congestion was assumed to be related to 
chronic heart disease. This was not supported by the relative risk statistics, but sample size was 
small. The finding of hepatocyte vacuolation is likely to be a secondary reactive change of the liver 
to a variety of other diseases. The prevalence of secondary hepatic lesions was very similar to that 
reported in a previous study in a number of breeds of dogs (Watson et al. 2010b).  
 
The authors considered whether an association might exist between the different abnormalities 
encountered. It was hypothesised that chronic pancreatitis might lead to an increased risk of 
glomerulonephritis due to the chronic inflammation and potential for immune complex deposition. 
Alternatively it was thought possible that chronic renal disease might cause pancreatitis, due to 
alterations in blood flow and an increase in circulating toxins. However in this study there was no 
increased risk of glomerulonephritis or interstitial nephritis in CKCS with chronic pancreatitis. It was 
equally considered that vacuolar hepatopathy may occur as a sequel to the chronic disease of chronic 
pancreatitis, however we found no evidence of an increased risk in this study. This agrees with a 
previous study (Watson et al. 2010b). That study did identify an increased relative risk of reactive 
hepatitis in dogs with chronic pancreatitis (Watson et al. 2010b). Only one dog in the current study 
was reported with reactive hepatitis so numbers were too small to investigate any potential 
association.  
 
A significant number of the dogs in this study had been diagnosed with cardiac disease or 
syringomyelia, a fact that is not surprising due to the high prevalence in this breed. It is possible that 
this could have had an impact on the other diseases of interest. However, a larger population would 
be required to explore this possibility further. 
 
There are a number of limitations to this study. The first is the retrospective nature of the study, 
which meant that the CKCS had been exposed to a number of different therapeutic regimes ante-
mortem, which may have impacted the findings. The study was also reliant on owners to provide 
accurate clinical information which means that some information may have been missing, and was a 
self-selected population which was likely to attract owners with an interest in CKCS diseases and 
potentially dogs with chronic disease. Investigating pancreatitis is also inherently difficult, as the 
lesions are not always uniformly distributed throughout the organ. Lastly, the grading of pancreatitis 
is relatively subjective. However all of the pancreas sections in this study were reviewed by one 
person, which should allow some consistency of interpretation. 
 
In summary, this is the first study to look at the prevalence of microscopic lesions of the liver, 
pancreas and kidney in the Cavalier King Charles Spaniel and it demonstrates a surprisingly high 
prevalence of chronic pancreatitis and renal disease in this breed (51.9% and 52.2% respectively), 
most of which were not diagnosed ante-mortem. The rates of hepatic disease are very similar to the 
general population. It is hoped that the results of this study will increase recognition and appropriate 
treatment of chronic pancreatitis and chronic kidney disease in Cavalier King Charles Spaniels, so 
improving the quality of life of affected dogs. Studies in the future should focus on understanding the 
reasons for these high disease prevalences in the breed.  
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Figure legends 
 
Fig. 1. Normal pancreas from a 10-year-old female CKCS. Most of the section consists of exocrine 
adenomeres with multiple pancreatic islets (arrows). H&E, bar: 300 μm. 
  
Fig. 2. Mild pancreatitis in a 12-year-old male CKCS, characterised by one area of dissecting fibrosis 
(F) with lymphocytic infiltrate. H&E, bar: 300 μm. 
  
Fig. 3. Example of moderate chronic pancreatitis in a 9-year-old male CKCS. Note multiple areas of 
dissecting fibrosis (arrow) with mononuclear inflammatory cells. H&E, bar: 300 μm. 
  
Fig. 4. Marked chronic pancreatitis in a 13-year-old female CKCS, note extensive fibrosis (F) 
containing lymphocytes surrounding remaining pancreatic tissue (arrow). The fibrosis takes up 
>50% of the section. H&E, bar: 300 μm. 
  
Fig. 5. Pancreas of a 16-year-old female CKCS with end stage chronic pancreatitis. Most of the 
pancreatic tissue has been replaced collagenous stroma admixed with blood vessels (S). Only a very 
small amount of remaining acinar tissue is found (arrow). The pancreas was not grossly visible at 
post mortem. H&E, bar: 300 μm. 
  
Fig. 6. An example of a kidney of a CKCS with glomerulonephritis and interstitial nephritis 
(arrows). H&E, bar: 300 μm. 
   
 
 
 
 
 
